title: Osteosarcoma studies at St. Jude Children's Research Hospital from 1968 through 1990.
authors.forename: C B
authors.initials: CB
authors.lastname: Pratt
authors.forename: W H
authors.initials: WH
authors.lastname: Meyer
authors.forename: B N
authors.initials: BN
authors.lastname: Rao
authors.forename: D M
authors.initials: DM
authors.lastname: Parham
authors.forename: I D
authors.initials: ID
authors.lastname: Fleming
mesh_terms: D000671:Amputation, Surgical; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D002648:Child; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D002955:Leucovorin / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary / Q000601:surgery; D015080:Mesna / Q000008:administration & dosage; D012516:Osteosarcoma / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary / Q000601:surgery; D016019:Survival Analysis; D013714:Tennessee / Q000453:epidemiology; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D015080:Mesna; D002945:Cisplatin; D002955:Leucovorin; D007069:Ifosfamide